Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data
Julia Bohlius(University of Bern), Andreas Engert(University of Cologne)
Cited by 151
Related Papers
Erythropoietin or darbepoetin for patients with cancer
|Cochrane Database of Systematic Reviews|2012|388
Immunochemotherapy With Rituximab and Overall Survival in Patients With Indolent or Mantle Cell Lymphoma: A Systematic Review and Meta-analysis
|JNCI Journal of the National Cancer Institute|2007|366
Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study
|Journal of Clinical Oncology|2012|261
Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group
|Journal of Clinical Oncology|2011|190
Recommendations for the use of rituximab (anti‐CD20 antibody) in the treatment of autoimmune bullous skin diseases<sup>§</sup>
|JDDG Journal der Deutschen Dermatologischen Gesellschaft|2008|137